A Nanohybrid of Prussian Blue Supported by Boracic Acid-Modified G-C3n4 for Raman Recognition of Cell Surface Sialic Acid and Photothermal/photodynamic Therapy.

Ya-Ning Wang,Wen-Shu Zhang,Xiao-Peng Liu,Yun-Yun Wei,Zhang-Run Xu
DOI: https://doi.org/10.1016/j.colsurfb.2022.112490
IF: 5.999
2022-01-01
Colloids and Surfaces B Biointerfaces
Abstract:Theranostic nanoplatforms with accurate diagnosis and effective therapy show a bright prospect for tumor treatments. Herein, a novel boracic acid-modified graphite carbon nitride and Prussian blue nanohybrid (PB@B-g-C3N4) was developed, which provides sialic acid-targeted Raman recognition and synergistic photothermal/ photodynamic therapy in the near-infrared region. Owing to the specific interaction between boracic acid and sialic acid and Raman response at 2157 cm(-1) of PB, the nanohybrids exhibit high specificity and Raman sensitivity for detection of the overexpressed sialic acid on tumor cells. Moreover, the photothermal conversion efficiency of PB@B-g-C3N4 is as high as 47.0% with 808 nm laser irradiation due to the enhanced absorbance of PB@B-g-C3N4. PB@B-g-C3N4 also possesses excellent photodynamic activity, which is attributed to the energy transfer of PB (type I) and electron transfer between PB and B-g-C3N4 (type II). This nanotheranostic agent for Raman recognition of cancer markers and synergistic photothermal/photodynamic therapy holds great potential for the development of efficient theranostic nanoplatforms.
What problem does this paper attempt to address?